encephalitis lethargica

encephalitis lethargica
en:Constantin von Economo · Public domain · source
Name	Encephalitis lethargica
Field	Neurology, Infectious disease
Symptoms	Somnolence, oculomotor disturbances, movement disorders, behavioral change
Complications	Parkinsonism, cognitive decline, sleep disturbance
Onset	Acute, subacute
Causes	Unknown; suspected infectious or postinfectious
Medication	Levodopa, immunotherapy, supportive care

encephalitis lethargica Encephalitis lethargica emerged as a distinct clinical syndrome in the early 20th century and produced a global outbreak that intersected with major historical events. Patients typically exhibited profound somnolence, ophthalmoplegia, behavioral change, and movement disorders, and the condition has been linked in the literature to sustained sequelae including postencephalitic parkinsonism. The disorder has attracted attention from clinicians, public health authorities, and authors documenting its impact during periods contemporaneous with figures and institutions across Europe and North America.

History and epidemiology

The most notable epidemic occurred from about 1916–1927, coinciding with the era of World War I, the Spanish influenza pandemic, and the interwar period that affected populations in cities such as London, Paris, and New York City. Contemporary reports came from clinicians affiliated with institutions like Johns Hopkins Hospital, Charité – Universitätsmedizin Berlin, and the Pasteur Institute, and were discussed in meetings of organizations such as the Royal Society of Medicine and the American Medical Association. Epidemiologists compared temporal patterns with mortality spikes in registries maintained by municipal authorities in Vienna, Madrid, and Milan, while neurologists publishing case series included authors connected to centers like Massachusetts General Hospital and the University of Vienna. Later surveillance during the mid-20th century and case clusters reported from regions including Buenos Aires, Tokyo, and Moscow prompted debate among experts at forums such as the World Health Organization and learned societies like the Society for Neuroscience about endemic versus epidemic behavior.

Clinical features and presentation

Patients classically presented with profound somnolence, delirium, oculomotor abnormalities, and movement disorders, with early accounts from neurologists at institutions such as Mayo Clinic, University College London, and Charité – Universitätsmedizin Berlin. Acute presentations described by physicians in correspondence with peers at Johns Hopkins Hospital, Massachusetts General Hospital, and Bellevue Hospital included fever, headache, and meningismus followed by stupor, while ophthalmoplegia and vertical gaze palsies were emphasized in case series published in journals associated with Oxford University Press and medical societies like the Royal Society of Medicine. Behavioral disturbances and psychiatric manifestations drew commentary from psychiatrists at institutions such as Brooklyn State Hospital, St. Elizabeths Hospital, and critics linked to cultural figures and hospitals in Vienna and Berlin. In the chronic phase, survivors developed parkinsonian features and neuropsychiatric decline documented by movement disorder groups at University of California, San Francisco and neurorehabilitation centers affiliated with Harvard Medical School.

Etiology and pathogenesis

The aetiology has remained controversial and was debated by investigators at the Pasteur Institute, Rockefeller Institute for Medical Research, and university laboratories in Zurich and Prague. Hypotheses advanced included direct viral invasion—investigators compared patterns to viruses studied at National Institutes of Health laboratories and to agents described by virologists at the Ecole Normale Supérieure—and postinfectious immune-mediated mechanisms discussed by immunologists associated with Institut Pasteur and the Karolinska Institutet. Bacteriological and autoimmune theories prompted studies using techniques developed at institutions such as University of Tokyo and McGill University, with neuropathologic descriptions reported from autopsies performed in pathology departments at Charité – Universitätsmedizin Berlin and Guy's Hospital. Molecular and serologic investigations in later decades at centers like the Pasteur Institute and Centers for Disease Control and Prevention explored links to respiratory viruses, while contemporary immunopathologic models reference work from researchers at Stanford University and University College London.

Diagnosis and differential diagnosis

Diagnosis relied on clinical pattern recognition by neurologists at referral centers such as Massachusetts General Hospital, University of Oxford, and King's College Hospital supported by cerebrospinal fluid analysis, neuroimaging studies pioneered at institutions like Mayo Clinic and electrophysiology labs at Johns Hopkins Hospital. Differential diagnosis included acute infectious encephalitides studied at the Centers for Disease Control and Prevention, autoimmune encephalitis subtypes characterized by investigators at University of Pennsylvania and Charité – Universitätsmedizin Berlin, metabolic encephalopathies evaluated in departments at Cleveland Clinic, and toxin-mediated syndromes reported to public health agencies in London and Washington, D.C.. Movement disorder mimics such as idiopathic Parkinson disease described by clinicians at University College London and Imperial College London are considered in follow-up assessments, as are psychiatric conditions historically managed at hospitals like Bellevue Hospital and St. Elizabeths Hospital.

Treatment and management

Management historically involved supportive care delivered in wards at institutions such as Massachusetts General Hospital and Bellevue Hospital, with later therapeutic trials of dopamine replacement—most notably levodopa—initiated in movement disorder centers at University College London, Mount Sinai Hospital, and University of California, San Francisco. Immunomodulatory approaches have been explored in clinical settings at Mayo Clinic, Johns Hopkins Hospital, and tertiary centers affiliated with Harvard Medical School, while rehabilitation strategies have been implemented by teams at Rancho Los Amigos National Rehabilitation Center and stroke and neurorehabilitation services at Guy's Hospital. Symptomatic management of sleep disturbance, dysautonomia, and psychiatric symptoms has been guided by multidisciplinary units connected to Karolinska Institutet and University of Toronto.

Long-term outcomes and complications

Long-term sequelae were documented by longitudinal cohort studies and case series from centers such as King's College Hospital, Mayo Clinic, and Massachusetts General Hospital describing persistent parkinsonism, cognitive impairment, and chronic sleep disorders that led to disability managed by services at Royal Prince Alfred Hospital and neuropsychiatry clinics at Johns Hopkins Hospital. Historic accounts of chronic institutionalized patients were recorded in the records of facilities like Pilgrim State Hospital and discussed in analyses by public health authorities in New York City and London. Outcomes varied, with some patients showing levodopa-responsive syndromes described at University College London and others experiencing progressive decline documented by researchers at University of California, San Francisco and University of Toronto.

Category:Neurological disorders